ATRX is hypothesized to play key roles in both normal and cancer cells, such as global epigenetic maintenance of pericentromeric heterochromatin, repression of alternative lengthening of telomeres (ALT), targeting of polycomb repressor complex 2, and regulation of DNA double strand break (DSB) damage repair (8–10). The gene discussed is ATRX; the disease is cancer.